The retina is part of the central nervous system, which also comprises the brain and spinal cord. Many diseases are linked to ...

Objective Glenohumeral (GH) osteoarthritis (OA) is the third most common large joint disease, after hip and knee OA. This ...

Staff at Smithsonian’s National Zoo in the District are mourning the death of a male gray seal, Gunther, at the age of 33, ...

MPs push for assisted dying to be expanded to people with a year left to live - MPs and campaigners say that people suffering ...

Researchers have conducted one of the largest eye studies ever, revealing that retinal thickness could play a key role in ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...

The National Institute for Fitness and Sport (NIFS) is gearing up for the third running of Pump it for Parkinson's on Thursday April 10, 2025. NIFS along with their program partner, NuStep, are ...

Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in ...

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to treat vision-threatening eye diseases, including wet age-related macular degeneration (wet AMD) and diabetic ...

Brian T. Feeley, MD, FAAOS, was bestowed with the 2025 Kappa Delta Elizabeth Winston Lanier Award for his research in advancing the understanding of muscle degeneration in rotator cuff injuries and ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Kappa Delta Ann Doner Vaughn Award was presented to Matthew T. Provencher, MD, MBA, CAPT MC USNR (Ret.), and his military orthopaedic colleagues for their work in understanding and treating anterior ...